Who Discovered Influenza Links


Swine Flu Vaccine Found To Give Broader Flu Protection

Africa: Remedying Global Health R&D

Analysis: Remedying global health R&D

Hospitals fall prey to difficult superbug

Avian Flu Study Finally And Fully Published

<< 1 2 3 >>




supercross racing Recommended Products

Who Discovered Influenza News

Swine Flu Vaccine Found To Give Broader Flu Protection - RedOrbit


RedOrbit
Swine Flu Vaccine Found To Give Broader Flu Protection
RedOrbit
Immunologists have wanted to develop a “universal” influenza vaccine for some time now. Because possible dangerous mutations of the flu can occur, there has always been a need for a new vaccine every year. The results come from a collaborative project ...

and more »

Read more...

MIDDLETON - Lucigen gets grant for influenza test - BizTimes.com (Milwaukee)


MIDDLETON - Lucigen gets grant for influenza test
BizTimes.com (Milwaukee)
Middleton-based Lucigen Corp. is getting a three-year, $2.8 million grant to develop a new kind of test for influenza. The Small Business Innovation Research grant is from the National Institutes of Health. Lucigen says it has discovered an enzyme that ...

and more »

Read more...

Remedying Global Health R&D - AllAfrica.com


Remedying Global Health R&D
AllAfrica.com
But an MSF survey of drugs developed from 1975 to 2004 found that only 18 out of 1556 were for such diseases. "We have no model which would meet the need for new drugs in a sustainable way," the head of pharmaceutical company Novartis told ...

and more »

Read more...

Theraclone Sciences Announces Positive Top-line Data from a Phase 1 Trial of ... - MarketWatch (press release)


Theraclone Sciences Announces Positive Top-line Data from a Phase 1 Trial of ...
MarketWatch (press release)
... a therapeutic antibody discovery and development company, today announced positive top-line data from its Phase 1 trial of TCN-032, a broadly protective, fully human monoclonal antibody, being developed for the treatment of influenza A infections.

and more »

Read more...

Theraclone Sciences Announces Positive Top-line Data from a Phase 1 Trial of ... - SunHerald.com


Theraclone Sciences Announces Positive Top-line Data from a Phase 1 Trial of ...
SunHerald.com
... a therapeutic antibody discovery and development company, today announced positive top-line data from its Phase 1 trial of TCN-032, a broadly protective, fully human monoclonal antibody, being developed for the treatment of influenza A infections.

and more »

Read more...